Early estrogen replacement therapy reverses the rapid loss of trabecular bone volume and prevents further deterioration of connectivity in the rat

Journal of Bone and Mineral Research

Volumn 14, Issue 2, 1999, Pages 206-214

  Lane, Nancy E ^a,d   Haupt, David ^b   Kimmel, Donald B ^c   Modin, Gunnar ^a   Kinney, John H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ATROPHY; BONE REMODELING; BONE TURNOVER; CANCELLOUS BONE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFECT; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; RAT; SUBSTITUTION THERAPY; THREE DIMENSIONAL IMAGING; TRABECULAR BONE;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE REMODELING; DISEASE MODELS, ANIMAL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TOMOGRAPHY, X-RAY;

EID: 0032934302     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1999.14.2.206     Document Type: Article

References (49)

1. Bouillon R, Burkhardt P, Christiansen C, Fleisch HA, Fujita T, Gennari C, Martin TJ, Mazzuoli G. Melton LJ, Ringe JD, et al. 1991 Consensus Development Conference: Prophylaxis and treatment of osteoporosis. Osteoporos Int 1:114-117.
2. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ 1985 Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 7:178-208.
3. Jergas M, Genant HK 1993 Current methods and recent advances in the diagnosis of osteoporosis. Arthritis Rheum 12:1649-1662.
4. Feldkamp LA, Goldstein SA, Parfitt AM, Jesion G, Kleerekoper M 1989 The direct examination of three-dimensional bone architecture in vitro by computed tomography. J Bone Miner Res 4:3-11.
5. Majumdar S, Newitt DC, Link TM, Augat P, Lin JC, Ouyang X, Lang T, Lotz J, Genant HK 1997 Three dimensional assessment of trabecular architecture using magnetic resonance imaging. Trans Orthopaed Res Soc 22:209.
6. Kinney JH, Lane NE, Haupt D 1995 Three dimensional in vivo microscopy of sequencial changes in trabecular architecture following estrogen depletion in female rats. J Bone Miner Res 10:264-270.
7. Lane NE, Thompson JM, Strewler GJ, Kinney JH 1995 Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats. J Bone Miner Res 10:1470-1477
8. Lane NE, Thompson JM, Haupt D, Kimmel DB, Modin G, Kinney JH 1998 Acute changes in trabecular bone connectivity and osteoclast activity in the ovariectomized rat in vivo. J Bone Miner Res 13:229-236.
9. Dempster DW, Birchman R, Xu R, Lindsay R, Shen V 1995 Temporal changes in cancellous bone structure in rats immediately after ovariectomy. Bone 16:157-161.
10. Boyce RW, Wronski TJ, Ebert DE, Stevens ML, Paddock CL, Youngs TA, Gundersen HJ 1995 Direct stereological estimation of three-dimensional connectivity in the rat vertebrae: Effect of estrogen, etidronate and risedronate following ovariectomy. Bone 16:209-213.
11. Lindsay R, Hart DM, Clark DM 1984 The minimal effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 63:759-764.
12. Chow J, Tobias H, Coston KW, Chambers TJ 1992 Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest 89:74-78.
13. Sims NA, Morris HA, Moore RJ, Durbridge TC 1996 Estradiol treatment transiently increases trabecular bone volume in ovariectomized rats. Bone 19:455-461.
14. Wronski TJ, Cintron M, Doherty AL, Dann LM 1988 Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123:681-686.
15. Kalu DN, Salerno E, Hollis B, Ray M 1991 Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol. Bone Miner 14:175-187.
16. Shen V, Dempster DW, Birchman R, Xu R, Lindsay R 1993 Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J Clin Invest 91:2479-2487.
17. Writing Group for PEPI 1996 Effect of hormone replacement therapy on bone mineral density: Results from the postmenopausal estrogen/progestin interventions (PEPI) Trial. JAMA 276:1389-1396.
18. Chavassieux PM, Arlot ME, Reda C, Wei L. Yates J, Menuier PJ 1997 Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 100:1475-1480.
19. Balena R, Markatos A, Seedor JG, Gentile M, Stark C, Peter CP, Rodan GA 1996 The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized non-human primates. J Clin Invest 92:2577-2586.
20. Sims NA, Morris HA, Moore RJ, Durbridge TC 1996 Increased bone resorption precedes increased bone formation in the ovariectomized rat. Calcif Tissue Int 59:121-127.
21. Menuier PJ, Confavreuz E, Tupinion I, Hardouin C, Delmas PD, Balena R 1997 Prevention of ealy postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo controlled study with 1 year follow-up. J Clin Endocrinol 82:84-89.
22. Mosekilde L, Danielson CC, Gasser J 1994 The effect on vertebral bone mass and strength of long-term treatment with anti-resorptive agents (estrogen and calcitonin). human parathyroid hormone-(1-38), and combination therapy, assessed in aged ovariectomized rats. Endocrinology 134:2126-2134.
23. Waynforth HB 1980 Experimental and Surgical Techniques in the Rat. Academic Press, New York, U.S.A.
24. Luo G, Kinney JH, Kaufman JJ, Haupt DL, Siffert RS 1997 Relationship of plain radiographic patterns to three dimensional trabecular architecture in the human calcaneous. Osteoporos Int (in press).
25. Parfitt AM 1983 The physiologic and clinical significance of bone histomorphometric data. In: Recker RR (ed.) Bone Histomorphometry: Techniques and Interpretation. CRC Press, Boca Raton, FL, U.S.A., pp. 143-224.
26. Hoshen J, Kopelman R 1976 Percolation and cluster distribution. I. Cluster multiple labeling technique and critical concentration algorithm. Phys Rev B 15:3438-3445.
27. Seyedin SM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, Rosen HN, Zuk RF 1993 Immunoassay for urinary pyridinoline: The new marker of bone resorption. J Bone Miner Res 8:635-641.
28. Delmas PJ, Schlemmer A, Gineyts E, Riis B, Christiansen C 1991 Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with osteoporosis. J Bone Miner Res 6:639-644.
29. Villanueva AR, Lundin KD 1989 A versatile new mineralized bone stain for simultaneous assessment of tetracycline and osteoid seams. Stain Technol 64:129-138.
30. Baron R, Vignery A, Neff L, Silvergate A, Santa Maria A 1983 Processing of undecalcified bone specimen for bone histomorphometry. Recker RR (ed.) Bone Histomorphometry: Techniques and Interpretation. CRC Press, Boca Raton, FL, U.S.A., pp. 13-35.
31. Goldner J 1938 A modification of the Masson trichorime technique for routine laboatory purposes. Am J Pathol 14:237-243.
32. Maeda H, Kimmel DB, Raab D, Lane NE 1993 The musculoskeletal response to immobilization and recovery. Bone 14:153-159.
33. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomencluature, symbols, and units. J Bone Miner Res 2:595-610.
34. Parfitt AM, Mathews CHE, Villanueva AR, Kleerehoper M, Frame B, Rao DS 1983 Relationships between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis. J Clin Invest 72:1396-1409.
35. Recker RR 1983 Bone Histomorphometry Techniques and Interpertations, Vol. 1. CRC Press, Boca Raton, FL, U.S.A.
36. Sokal R, Rohlf FJ 1969 Biometry. Freeman, San Francisco, CA, U.S.A.
37. Recker RR 1993 Architecture and vertebral fracture. Calcif Tissue Int 53 (Suppl 1):139-142.
38. Ettinger B, Genant HK, Cann CE 1987 Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med 106:40-45.
39. Wronski TJ, Yen C-F, Qi H, Dann LM 1993 Parathyroid hormone is more effective than estrogen or bisophosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology 132:823-831.
40. Prestwood KM, Pilbeam CC, Burleson JA, Woodiel FN, Delmas PB, Deftos LJ, Raisz LG 1994 The short-term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab 79:366-371.
41. Riis BJ, Overgaard K, Christiansen C 1995 Biochemical markers of bone turnover to monitor the obne response to postmenopausal hormone replacement therapy. Osteoporos Int 5:276-280.
42. Garnero P, Shih WJ, Gineyts E, Karpt DB, Delmas PD 1994 Comparison on new biochemical markers of bone turnover in late postmenopausal hormone replacement therapy. Osteoporos Int 5:276-280.
43. Shen V, Birchman R, Xu R, Lindsay R, Dempster DW 1995 Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen-and/or dietary calcium-deficient rats. Bone 16:149-156.
44. Kiel DP, Felson DT, Anderson JJ, Wilson PWF, Moskowitz MA 1987 Hip fracture and the use of estrogens in postmenopausal women: The Framingham Study. N Engl J Med 317:1169-1174.
45. Frolik CA, Bryant HU, Black EC, Magee DE, Chandraseakhar S 1996 Time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: Effects of raloxifene HCL, tamoxifen, estrogen, and alendronate. Bone 18:621-627.
46. Chachra D, Kasra M, Vanin CM, MacLusky NJ, Casper RF, Grynpas MD 1995 The effect of different hormone replacement therapy regimens on the mechanical properties of rat vertebrae. Calcif Tissue Int 56:130-134.
47. Lieberman UA, Weiss SR, Broll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW, Dequeker J, Favus M 1995 Effect of alendronate on bone mineral density and incidence of fractures in postmenopausal osteoporotic women. N Engl J Med 333:1437-1443.
48. Black DB, Cummings SR, Karpt DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskett WJ, Marcus M, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE 1996 Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:15351541.
49. Li M, Shen MLY, Qi H, Wronski TJ 1996 Comparative study of skeletal response to estrogen depletion at red and yellow marrow sites in rats. Anat Rec 245:472-480.